# Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)

Study · id `cardio:ct-nct02879825` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02879825](<https://clinicaltrials.gov/study/NCT02879825>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02879825

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 239 participants.

## Technical summary

Registry record NCT02879825. Non-randomized; no masking; primary purpose diagnostic. Start 2016-12-20 (actual); primary completion 2021-05-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 239 participants (enrolled count; ClinicalTrials.gov record NCT02879825, source copy `cardio:ctgov-nct02879825-2022-02-03`, retrieved 2026-10-26)
- Started: 2016-12-20 (actual) (ClinicalTrials.gov record NCT02879825, source copy `cardio:ctgov-nct02879825-2022-02-03`, retrieved 2026-10-26)
- Primary completion: 2021-05-31 (actual) (ClinicalTrials.gov record NCT02879825, source copy `cardio:ctgov-nct02879825-2022-02-03`, retrieved 2026-10-26)
- Completion: 2021-05-31 (actual) (ClinicalTrials.gov record NCT02879825, source copy `cardio:ctgov-nct02879825-2022-02-03`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02879825, source copy `cardio:ctgov-nct02879825-2022-02-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02879825-2022-02-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Myocardial Characterization of Arrhythmogenic Mitral Valve Prolapse (STAMP: STretch and Myocardial Characterization in Arrhythmogenic Mitral Valve Prolapse)
- Acronym: STAMP
- Condition: Mitral Valve Prolapse
- Intervention (Device): Cardiac MRI
- Lead sponsor: Central Hospital, Nancy, France
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral valve prolapse (`cardio:mitral-valve-prolapse`)
- Registry condition terms include this condition: Premature heartbeats (`cardio:premature-heartbeats`)
- Registry lists this organization as the lead sponsor: Central Hospital, Nancy, France (`cardio:org-central-hospital-nancy-france`)

## Provenance

Content hash: 730743c84978cf4152b37274f94d73aa7723293977a808b99676e1d1ace80ab9
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
